MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

Adaptive Biotechnologies Corp

Fermé

7.88

Résumé

Variation du prix de l'action

24h

Actuel

Min

7.82

Max

7.9

Chiffres clés

By Trading Economics

Revenu

-1.6M

-34M

Ventes

1M

47M

BPA

-0.228

Marge bénéficiaire

-71.044

Employés

619

EBITDA

-1.8M

-26M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+21.29% upside

Dividendes

By Dow Jones

Prochains Résultats

1 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-108M

1.1B

Ouverture précédente

7.88

Clôture précédente

7.88

Score Technique

By Trading Central

Confiance

Neutral Evidence

Adaptive Biotechnologies Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

25 avr. 2025, 17:01 UTC

Résultats
Principaux Mouvements du Marché

Aon Shares Sink After 1Q Profit Falls, Sales Miss Estimates

25 avr. 2025, 16:10 UTC

Résultats
Principaux Mouvements du Marché

Coursera Shares Rise After 1Q Beat, Better-Than-Expected Revenue View

26 avr. 2025, 18:14 UTC

Résultats

Tech Executives Are Starting to Talk Tariffs. What It May Mean for Apple, Amazon Earnings -- Barrons.com

26 avr. 2025, 15:00 UTC

Résultats
Acquisitions, Fusions, Rachats

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

26 avr. 2025, 08:20 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

25 avr. 2025, 21:24 UTC

Actualités

Cargo Shipments From China to the U.S. Dwindle -- WSJ

25 avr. 2025, 20:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

25 avr. 2025, 20:45 UTC

Actualités

Stocks Claw Back Most of April's Tariff Losses -- WSJ

25 avr. 2025, 20:39 UTC

Résultats

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week -- WSJ

25 avr. 2025, 20:37 UTC

Actualités

Trump Administration Lays Out Tariff Roadmap to Streamline Trade Talks -- WSJ

25 avr. 2025, 20:19 UTC

Actualités

Nasdaq Climbs More Than 1% as Stocks Finish Strong Week -- WSJ

25 avr. 2025, 20:15 UTC

Résultats

Week's Best: A Dividend Expert's Best Advice -- Barrons.com

25 avr. 2025, 19:23 UTC

Market Talk

U.S. Natural Gas Futures Extend Weekly Losses -- Market Talk

25 avr. 2025, 19:18 UTC

Market Talk

Oil Futures End Choppy Week With Losses -- Market Talk

25 avr. 2025, 18:47 UTC

Market Talk

Gold Extends Pullback to Close Week -- Market Talk

25 avr. 2025, 18:39 UTC

Actualités

Nasdaq, Dow Industrials About Flat; Analysts Caution on Trump Tariffs -- WSJ

25 avr. 2025, 18:34 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs Upgrades Schwab Stock. Here's Why. -- Barrons.com

25 avr. 2025, 18:32 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

25 avr. 2025, 18:32 UTC

Market Talk
Résultats

Carriers See Tariffs Driving Up Phone Prices, Slowing Upgrades -- Market Talk

25 avr. 2025, 18:08 UTC

Résultats

Sphere Entertainment Deal Is a Win for Shareholders as Banks Take a Hit -- Barrons.com

25 avr. 2025, 17:55 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 483 -- Market Talk

25 avr. 2025, 17:40 UTC

Actualités

Consumers Continue to Sour on the Economy -- 4th Update

25 avr. 2025, 17:38 UTC

Résultats

Centene Stock Falls on Medicaid Cost Worries -- Barrons.com

25 avr. 2025, 17:07 UTC

Market Talk

Oil Futures Turn Higher in Quiet Trade -- Market Talk

25 avr. 2025, 16:54 UTC

Market Talk
Résultats

Mobile Carriers See Stronger Activity on Bigger Price Tags, Tariffs -- Market Talk

25 avr. 2025, 16:46 UTC

Résultats

Reddit, Meta, and Pinterest Stocks Rise. How Alphabet's Earnings Are Giving Them a Boost. -- Barrons.com

25 avr. 2025, 16:20 UTC

Market Talk
Résultats

Basic Materials Roundup: Market Talk

25 avr. 2025, 16:12 UTC

Actualités

Dow Industrials Fall; China Plans Economic Support During Trade Battle -- WSJ

25 avr. 2025, 16:03 UTC

Résultats

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts -- Barrons.com

25 avr. 2025, 15:52 UTC

Market Talk

Grains Mixed on Low Volume Trade -- Market Talk

Comparaison

Variation de prix

Adaptive Biotechnologies Corp prévision

Objectif de Prix

By TipRanks

21.29% hausse

Prévisions sur 12 Mois

Moyen 9.57 USD  21.29%

Haut 12 USD

Bas 7 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

7 ratings

6

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

7.39 / 8.03Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Weak Bullish Evidence

Long Terme

Weak Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.